Following its acquisition of Accelrys in February, Dassault Systèmes has brought together all its life science activities under the single brand of 'Biovia'.
The new brand is a combination of Dassault Systèmes’ own activities in BioIntelligence, its collaborative 3DExperience technologies, and the life sciences and material sciences applications from the recent acquisition of Accelrys.
Biovia will focus on biological, chemical, and materials modelling and simulation, research and open collaborative discovery, enterprise laboratory and quality management, and process manufacturing intelligence.
‘Accelrys’ strategy is to provide customers with solutions and tools that will enable them to optimise the scientific innovation lifecycle from discovery to commercialisation,’ said Dick Slansky, Senior Analyst PLM & Industry at ARC Advisory Group. ‘The acquisition of Accelrys by Dassault Systèmes will make the Accelrys scientific innovation platform available to enrich Dassault Systèmes’ molecular chemistry capabilities in the life sciences, CPG and manufacturing industry sectors.’
The integration of the company’s 3DExperience platform with Accelrys’ strong suite of applications opens up the opportunity to support and develop collaboration, project management, data and content reuse, traceability, and other processes for scientific industries, especially pharmaceutical companies. Biovia will provide enterprise-wide scientific, biological, chemical and material solutions, with access and delivery through Dassault Systèmes’ 3DExperience business platform.
‘Today is an important day for Dassault Systèmes and one which I, personally, have been looking forward to for several years. Dassault Systèmes’ previous research programmes in life sciences and BioIntelligence were precursors to today’s new brand and capabilities,’ said Bernard Charlès, President and CEO of Dassault Systèmes. ‘The integration of Accelrys’ powerful applications with our 3DExperience platform will create a new collaborative environment for advanced biological, chemical, and materials experience development. With the power of Biovia, we will model the entire biosphere.’
Aside from the pharmaceutical and biotech industries, manufacturing companies, including Boeing, Toyota, Samsung and others, are expected to be users of Biovia solutions to research new materials, such as smart coatings, lighter, stronger composites, and eco-sustainable materials.
The acquisition of Accelrys and the integration of several capabilities within the new entity of Biovia appears to be part of a wider trend to consolidate disparate software packages under one over-arching Product Lifecycle Management (PLM) program. Biovia offers the ability to manage product information at the molecular level in a scalable manner throughout the value chain and, according to Michael Shanler, Research Director at Gartner: ‘PLM software users focused on commercialisation and new product introduction will be exposed to R&D tools that expand product innovation and multichannel opportunities.’
